Candel Therapeutics, Inc. (CADL)

NASDAQ: CADL · Real-Time Price · USD

10.51

+0.44 (4.37%)

At close: Aug 4, 2026, 4:00 PM EDT

10.45

-0.06 (-0.57%)

Pre-market: Aug 5, 2026, 4:39 AM EDT

Candel Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	194.83	119.73	102.65	35.41	70.06	82.64
Cash & Short-Term Investments	194.83	119.73	102.65	35.41	70.06	82.64
Cash Growth	111.40%	16.63%	189.88%	-49.45%	-15.23%	135.76%
Other Current Assets	2.92	1.66	1.15	1.38	1.89	2.3
Total Current Assets	197.75	121.39	103.8	36.8	71.95	84.95
Net Property, Plant & Equipment	3.64	3.3	2.73	4.02	5.48	3.84
Other Long-Term Assets	0.52	0.5	0.33	0.38	0.27	0.42
Total Assets	201.92	125.2	106.87	41.2	77.69	89.21

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.04	1.13	0.24	0.42	0.38	1.59
Accrued Expenses	3.47	7.33	5.11	4.36	4.72	3.44
Current Portion of Long-Term Debt	-	-	9.9	8.89	-	-
Current Portion of Leases	0.45	0.45	0.57	0.51	0.46	-
Other Current Liabilities	0.09	0.09	21.72	-	0.05	0.33
Total Current Liabilities	7.05	9	37.53	14.18	5.62	5.36
Long-Term Debt	47.48	47.13	2.6	12.38	20.85	0.56
Long-Term Leases	1.34	1.46	0.41	0.97	1.49	-
Other Long-Term Liabilities	8.02	15.69	-	0.92	2.03	19.15
Total Long-Term Liabilities	56.84	64.28	3.01	14.27	24.36	19.71
Total Liabilities	63.89	73.27	40.54	28.46	29.98	25.07

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.73	0.55	0.47	0.29	0.29	0.29
Treasury Stock	-0.45	-0.45	-0.45	-0.45	-0.45	-
Additional Paid-in Capital	376.99	282.21	258.51	149.93	146.96	144.15
Retained Earnings	-239.25	-230.39	-192.21	-137.03	-99.09	-80.3
Shareholders' Equity	138.03	51.92	66.33	12.75	47.71	64.14
Total Liabilities & Equity	201.92	125.2	106.87	41.2	77.69	89.21

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	49.27	49.03	13.47	22.76	22.8	0.56
Net Cash (Debt)	145.56	70.7	89.18	12.65	47.26	82.08
Net Cash Growth	79.15%	-20.73%	604.95%	-73.23%	-42.43%	140.66%
Net Cash Per Share	2.60	1.33	2.82	0.44	1.64	4.35
Book Value	138.03	51.92	66.33	12.75	47.71	64.14
Book Value Per Share	2.47	0.98	2.09	0.44	1.66	3.40
Tangible Book Value	138.03	51.92	66.33	12.75	47.71	64.14
Tangible Book Value Per Share	2.47	0.98	2.09	0.44	1.66	3.40

SEC Filings: 10-K · 10-Q